http://www.zacks.com/stock/news/891904/is-a-beat-in-store-for-perrigo-prgo-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-891904
Apr 27, 2020 - Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be-reported quarter.
zc:3158776358406111113
0
https://www.fool.com/investing/2020/04/13/2-crazy-cheap-buffett-stocks-to-buy-now.aspx?source=iedfolrf0000001
Apr 13, 2020 - Berkshire Hathaway and Teva Pharmaceutical Industries Ltd. are absurdly cheap right now.
0
fool:4148121574833030590
0
http://www.zacks.com/stock/news/859627/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-859627
Apr 07, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.54 in the latest trading session, marking a +0.85% move from the prior day.
zc:-6985581566052504566
0
https://seekingalpha.com/news/3558659-ubs-still-bullish-on-teva-despite-trimming-fair-value-target-shares-up-9?source=feed_sector_healthcare
Apr 06, 2020 - In a note, UBS reiterates its Buy rating on Teva Pharmaceutical Industries (TEVA +8.5%) albeit with a revised price target of $12 (from $14).Analyst Kevin Caliendo believes the company is relatively i
0
sa:-978794951068907760
0
https://www.fool.com/investing/2020/04/05/3-warren-buffett-stocks-i-absolutely-positively-wo.aspx?source=iedfolrf0000001
Apr 05, 2020 - The Oracle of Omaha owns some fantastic stocks in his Berkshire Hathaway portfolio. These aren't in the group.
0
fool:-2821613736516374496
0
https://seekingalpha.com/news/3556858-teva-prevails-in-migraine-patent-dispute-lilly-shares-up-9?utm_source=feed_news_all&utm_medium=referral
Mar 31, 2020 - The USPTO's Patent Trial and Appeal Board has upheld three patents protecting Teva Pharmaceutical Industries' (TEVA +9.0%) migraine med Ajovy (fremanezumab-vfrm) that were challenged by Eli Lilly (LLY
0
sa:1469575878018985290
0
https://seekingalpha.com/news/3556858-teva-prevails-in-migraine-patent-dispute-shares-up-9?source=feed_sector_healthcare
Mar 31, 2020 - The USPTO's Patent Trial and Appeal Board has upheld three patents protecting Teva Pharmaceutical Industries' (TEVA +9.0%) migraine med Ajovy (fremanezumab-vfrm) that were challenged by Eli Lilly (LLY
0
sa:-7240708732400087639
0
https://www.fool.com/investing/2020/03/31/3-ridiculously-cheap-buffett-stocks-to-buy-now.aspx?source=iedfolrf0000001
Mar 31, 2020 - It's been a while since the Oracle of Omaha had bargains like this in his portfolio.
0
fool:7292571830507266484
0
https://www.fool.com/investing/2020/03/30/fda-authorizes-use-of-old-malaria-drugs-to-treat-c.aspx?source=iedfolrf0000001
Mar 30, 2020 - Despite scant clinical evidence that they work, the FDA issued its first emergency use authorization for therapeutic products to treat the novel coronavirus.
0
fool:3385133350246049619
0
http://www.zacks.com/stock/news/845181/novartis-reports-data-on-inclisiran-chmp-positive-on-zolgensma?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845181
Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.
zc:8148599713700478305
0